208 LUPIN LIMITED Integrated Report 2021-22

Business Responsibility
& Sustainability Report (BRSR)
SECTION A: GENERAL DISCLOSURES
1. Details of the listed entity
Corporate Identity Number (CIN) of the Listed Entity L24100MH1983PLC029442
Name of the Listed Entity Lupin Limited
Year of incorporation 1983
Registered office address Kalpataru Inspire, 3rd Floor, Off Western Express
Highway, Santacruz (East), Mumbai - 400 055. India
Corporate address Kalpataru Inspire, 3rd Floor, Off Western Express
Highway, Santacruz (East), Mumbai - 400 055. India
E-mail hosecretarial@lupin.com
Telephone + 91 22 6640 2323
Website www.lupin.com
Financial year for which reporting is being done FY 2021-22
Name of the Stock Exchange(s) where shares are listed BSE, NSE
Paid-up Capital INR 909.0 Mn
Name and contact details (telephone, email address) Ramesh Swaminathan,
of the person who may be contacted in case of any Executive Director, Global CFO & Head – Corporate Affairs
queries on the BRSR report + 91 22 6640 2323
hosecretarial@lupin.com
Reporting Boundary Standalone

2. Products/services
Details of business activities (accounting for 90% of the turnover):

S. no. Description of main activity Description of business activity % of turnover of the entity (FY22)
1 Manufacture of Pharmaceuticals Manufacturing and sales of 90.82
Pharmaceuticals

3. Products/Services sold by the entity (accounting for 90% of the entity’s Turnover):
S. no. Product/Service NIC Code % of total turnover contributed
1 Manufacture of Pharmaceuticals 210 Medical and Healthcare 100

4. Number of locations where plants and/or operations/offices of the entity are situated:
Location Number of plants Number of offices Total
National 12 18 30
International NA 64
3 3

5. Markets served by the entity:

a. Number of locations

Locations Number
National (No. of States) 28 and 8 Union territories
International (No. of Countries) 65

b. What is the contribution of exports as a percentage of the total turnover of the entity?
Over 45.5% of the Company’s total revenue (standalone) can be attributed to its earnings from exports.
c. A brief on types of customers
Our customers are key stakeholders in our operations. We have an extensive customer base and reach in the generics
and the OTC drug markets. The company’s medicines cater to several health segments, including cardiology,
respiratory, gynaecology and gastrointestinal benefitting a diverse our range of patients. Health Care Providers
(HCPs) and Government Institutions to whom we sell our products are also our critical customer groups.

64
There are 3 International Plants owned by Lupin Subsidiaries. However, as the reporting boundary is standalone, this number has not been included in the BRSR
 Corporate Overview Statutory Reports Financial Statements 209

6. Employees (India)
Details as at the end of Financial Year:
a. Employees and workers (including differently abled):

S. Particulars Total Male Female

No. (A) No. (B) % (B/A) No. (C) % (C/A)
EMPLOYEES
1. Permanent (D) 18,325 17,269 94.23 1,056 5.76
2. Other than Permanent (E) 6,432 NA NA NA NA
3. Total employees (D+E) 24,757 17,269 94.23 1,056 5.76
WORKERS
4. Permanent (F) 1,128 1,116 98.9 12 1.1
5. Other than Permanent (G) NA NA NA NA NA
6. Total workers (F+G) 1,128 1,116 98.9 12 1.1
7. Total Permanent Workforce 19,453

b. Differently-abled Employees and workers

Being a diverse and inclusive organization is critical to the success of our operations. All efforts are made to ensure
that we provide an inclusive working environment and are able to attract and retain diverse talent. We are proud to
identify ourselves as ‘Equal Opportunity Employer’. Our workforce comprises of individuals with diverse skill sets, varied
backgrounds and abilities. We employ differently-abled people at our offices and plants in roles suitable for them.

7. Participation/Inclusion/Representation of women65
Total No. and percentage of Females
(A) No. (B) % (B/A)
Board of Directors 10 4 40
Key Management Personnel 4 1 25

8. Turnover rate for permanent employees and workers

Category India
Number of Employees at the beginning of FY22 18,925
Number of Employees at the end of FY22 19,453
Average number of Employees 19,189
Number of Employees left 3,389
Number of New Employees Hired 3,917
Turnover Rate 17.7%

9. Holding, Subsidiary and Associate Companies (including joint ventures)

(a) Names of holding/subsidiary/associate companies/joint ventures
S. Name of the holding/subsidiary/ Indicate whether holding/ % of shareholding
No. associate companies/joint Subsidiary/Associate/Joint
ventures (A) Venture
1. Lupin Inc., USA Subsidiary 100%
2. Lupin Pharmaceuticals, Inc., USA Subsidiary 100%
3. Pharma Dynamics (Proprietary) Subsidiary 100%
Limited, South Africa
4. Hormosan Pharma GmbH, Subsidiary 100%
Germany
5. Multicare Pharmaceuticals Subsidiary 51%
Philippines, Inc., Philippines
6. Generic Health Pty Limited, Subsidiary 100%
Australia
7. Nanomi B.V., Netherlands Subsidiary 100%
8. Lupin Atlantis Holdings SA, Subsidiary 100%
Switzerland

3 KMPs are also part of the Board of Directors.

65
210 LUPIN LIMITED Integrated Report 2021-22

S. Name of the holding/subsidiary/ Indicate whether holding/ % of shares held by listed entity
No. associate companies/joint Subsidiary/Associate/Joint
ventures (A) Venture

9. Lupin Healthcare (UK) Limited, UK Subsidiary 100%

10. Lupin Australia Pty Limited, Subsidiary 100%
Australia
11. Lupin Pharma Canada Limited, Subsidiary 100%
Canada
12. Lupin Mexico S.A. de C.V., Mexico Subsidiary 100%
13. Bellwether Pharma Pty Limited, Subsidiary 100%
Australia
14. Lupin Philippines Inc., Philippines Subsidiary 100%
15. Lupin Healthcare Limited, India Subsidiary 100%
16. Generic Health SDN. BHD., Malaysia Subsidiary 100%
17. Laboratoris Grin S.A. de C.V., Subsidiary 100%
Mexico
18. Medquimica Industria Farmaceutica Subsidiary 100%
LTDA, Brazil
19. Novel Laboratories, Inc., USA Subsidiary 100%
20. Lupin Research Inc., USA Subsidiary 100%
21. Avenue Coral Springs, LLC, USA Subsidiary 100%
22. Lupin Management, Inc., USA Subsidiary 100%
23. Lupin Europe GmbH, Germany Subsidiary 100%
24. Lupin Biologics Limited, India Subsidiary 100%
25. Lupin Oncology Inc., USA Subsidiary 99.3%
26. Lupin Digital Health Limited, India Subsidiary 100%
27. Southern Cross Pharma Pty Subsidiary 100%
Limited, Australia
28. YL Biologics Limited, Japan Joint Venture 45%
29. Lupin Foundation, India Subsidiary 100%

10. CSR Details

(i) Whether CSR is applicable as per section 135 of Companies Act, 2013: (Yes/No) - Yes
(ii) Turnover - INR 117,716.7 Mn
(iii) Net worth - INR 181,501.4 Mn

11. Transparency and Disclosures Compliances

Complaints/Grievances on any of the principles (Principles 1 to 9) under the National Guidelines on Responsible
Business Conduct:
Lupin stakeholders include our communities, investors, customers, employees, channel partners/franchises, regulators,
and research analyst. A strong whistle-blower policy and non-retaliation clause is available to all our stakeholders.
Our whistle-blower policy is available at https://www.lupin.com/pdf/Whistleblower-Policy.pdf. For details on investor
complaints, refer to the ‘Investor contacts’ on our website

12. Overview of the entity’s material responsible business conduct issues

Please indicate material responsible business conduct and sustainability issues pertaining to environmental and
social matters that present a risk or an opportunity to your business, rationale for identifying the same, approach to
adapt or mitigate the risk along-with its financial implications, as per the following format
Please refer to the chapter “Our Materiality Assessment-FY22” on page 22
 Corporate Overview Statutory Reports Financial Statements 211

SECTION B: MANAGEMENT AND PROCESS DISCLOSURES

This section is aimed at helping businesses demonstrate the structures, policies and processes put in place
towards adopting the NGRBC Principles and Core Elements.

S. Principle Description Reference of LUPIN Policies

No.
P1 Businesses should conduct and govern themselves Refer to our Code of Conduct web page
with integrity, and in a manner that is Ethical, https://www.lupin.com/investors/code-of-conduct/
Transparent and Accountable.
P2 Businesses should provide goods and services in a Refer to Third party Code of Conduct on
manner that is sustainable and safe https://www.lupin.com/investors/policies/
P3 Businesses should respect and promote the well-being Refer to the EHS&S Policy on
of all employees, including those in their value chains https://www.lupin.com/investors/policies/
P4 Businesses should respect the interests of and be Refer to Whistleblower policy on
responsive to all its stakeholders https://www.lupin.com/investors/policies/
P5 Businesses should respect and promote human rights Refer to the Human Rights Policy on
https://www.lupin.com/investors/policies/
P6 Businesses should respect and make efforts to protect Refer to the Corporate Social Responsibility Policy on
and restore the environment https://www.lupin.com/investors/policies/
P7 Businesses, when engaging in influencing public and Details of our interaction with industry associations
regulatory policy, should do so in a manner that is have been provided in Principle 7
responsible and transparent
P8 Businesses should promote inclusive growth and Refer to the Human Rights Policy on
equitable development https://www.lupin.com/investors/policies/
P9 Businesses should engage with and provide value to The safety of all our products is managed and
their consumers in a responsible manner monitored using strong systems and processes by the
Pharmacovigilance function.
We have also launched a Global Quality Action Plan
to ensure that the highest standards of product safety
and quality are adhered to within our operations.
Additionally, our team tracks and addresses customer
grievances brought forth by stakeholders such as
regulators and customers.

Disclosure Questions P P P P P P P P P
1 2 3 4 5 6 7 8 9
Policy and management processes
1. a. Whether your entity’s policy/ Y Y Y Y Y Y Y Y Y
policies cover each principle
and its core elements of the
NGRBCs. (Yes/No)
b. Has the policy been approved Y Y Y Y Y Y Y Y Y
by the Board? (Yes/No)
c. Web Link of the Policies, P1 – P9 - Lupin Code of Conduct on https://www.lupin.com/investors/code-of-conduct/
if available** P1 - Whistleblower Policy on https://www.lupin.com/investors/policies/
P2 – Refer to Third Party Code of Conduct https://www.lupin.com/investors/policies/
P3 – P5 – Refer to Human Rights Policy
https://www.lupin.com/investors/policies/
P4 – Refer to Corporate Social Responsibility Policy
https://www.lupin.com/investors/policies/
P7 – P8 – Refer to Corporate Social Responsibility Policy
https://www.lupin.com/investors/policies/
P9 – Refer to EHS&S Policy
https://www.lupin.com/investors/policies/

2. W
 hether the entity has Y Y Y Y Y Y Y Y Y
translated the policy into
procedures. (Yes/No)
212 LUPIN LIMITED Integrated Report 2021-22

3. Do the enlisted policies extend Y Y Y Y Y Y Y Y Y

to your value chain partners?
(Yes/No)
Refer to Third Party Code of Conduct https://www.lupin.com/investors/policies/
4. Name of the national and international codes/certifications/labels/standards (e.g. Forest Stewardship Council,
Fairtrade, Rainforest Alliance, Trustee) standards (e.g. SA 8000, OHSAS, ISO, BIS) mapped to each principle.

The following certifications have been received by the company:

1. Information Security System (ISO 27001:2013)
2. ISO 8 Class 100,000 Cleanrooms Standards
3. Good Manufacturing Practice (GMP) compliance across facilities
4. Several facilities have received US FDA, UK MHRA, WHO and Japanese PDMA accreditations
5. Our Goa facility received clearance from the US FDA in FY22

5. S
 pecific commitments, goals and targets set by the Environmental targets:
entity with defined timelines, if any.
• Project Plan for Rooftop Installation by FY23:
• Nagpur: 1500 KW
• Ankleshwar: 400 KW
• Scope 1 and 2 emissions reduction by 2030: 15%
• 50% of the total water withdrawn in Indian sites to
be recycled and reused in own operations by 2025
• 60% of total hazardous waste generated in
operations in India to be sent for co-processing to
cement plants
Supply chain targets:
• Implementation of Lupin’s Third-Party Code of
Conduct for all suppliers and vendors by 2022
• Undertaking detailed ESG audits of 100% of our
Tier 1 and Tier 2 suppliers by 2025
• Incorporation of ESG aspects in the evaluation
criteria for onboarding all new vendors by 2025
Social targets
• Diversity target: 15% women employees across
all business units by 2027
• CSR target: Plant 1,600,000 trees by 2025
• 10% year on year reduction in the Lost Time Injury
Frequency Rate (LTIFR), Severity Rate, Accident
Frequency Rate, and Incident Frequency Rate,
taking FY20 as the base year

6. P
 erformance of the entity against the specific Our performance across various environmental and social
commitments, goals and targets along-with reasons in parameters have been mentioned in the Natural Capital,
case the same are not met. Human Capital and Social Capital chapters of the IR

Governance, leadership and oversight

7. S
 tatement by director responsible for the business responsibility report, highlighting ESG related challenges,
targets and achievements (listed entity has flexibility regarding the placement of this disclosure)
“Lupin is committed to make the business sustainable and socially responsible. The Company’s ESG targets are
outlined on page 55, 85-86, 91, 102 and 111-113. We are partnering with some of our stakeholders to shape solutions
for sustainable future.”

Ramesh Swaminathan,
Executive Director, Global CFO & Head – Corporate Affairs
 Corporate Overview Statutory Reports Financial Statements 213

8. D
 etails of the highest authority responsible for Ramesh Swaminathan,
implementation and oversight of the Business Executive Director, Global CFO & Head – Corporate Affairs
Responsibility policy/policies
9. Does the entity have a specified Committee of the Yes.
Board/Director responsible for decision making on The ESG Core Committee is responsible for decision-
sustainability related issues? (Yes/No). If yes, making on sustainability related issues. It is chaired by the
provide details. CFO of the Company and meets once a month to discuss
progress and actions on ESG initiatives, targets and
implementation.

10. Details of Review of NGRBCs by the Company:

Subject for Review Indicate whether review was Frequency (Annually/Half yearly/Quarterly/
undertaken by Director/Committee Any other – please specify)
of the Board/Any other Committee
P P P P P P P P P P P P P P P P P P
1 2 3 4 5 6 7 8 9 1 2 3 4 5 6 7 8 9
Performance against above The ESG Core Committee at Lupin and the Board reviews the Company’s
policies and follow up action performance across all aspects of the nine principles of the NGRBC periodically.
Certain targets have also been taken on the environmental and social aspects of our
business, which is further elaborated upon in the IR section of this report.

Compliance with statutory Lupin strives to maintain the highest degree of conformance and compliance with
requirements of relevance to the laws of the land in all locations of our operations. Any statutes and legislation
the principles, and, rectification pertaining to the nine principles of the NGRBC are complied with.
of any non-compliances
We have been publishing our Business Responsibility Report annually and
starting this year, we have voluntarily adopted the BRSR mandate to disclose our
performance on the nine principles of the BRSR.

11. Has the entity carried out P P P P P P P P P

independent assessment/
1 2 3 4 5 6 7 8 9
evaluation of the working
of its policies by an external
agency? (Yes/No). If yes, No.
provide name of the agency.

12. If answer to question (1) above is “No” i.e. not all Principles are covered by a policy, reasons to be stated:
NA

Questions P P P P P P P P P
1 2 3 4 5 6 7 8 9
The entity does not consider The entity has conducted a materiality assessment to identify the ESG issues relevant
the principles material to its to the business and we have defined our management approach for each of these.
business (Yes/No) Please refer to the chapter “Our Materiality Assessment-FY 22” on page 22
214 LUPIN LIMITED Integrated Report 2021-22

SECTION C: PRINCIPLE WISE PERFORMANCE DISCLOSURE

This section is aimed at helping entities demonstrate their performance in integrating the Principles and Core Elements
with key processes and decisions. The information sought is categorized as “Essential” and “Leadership”. While the
essential indicators are expected to be disclosed by every entity that is mandated to file this report, the leadership
indicators may be voluntarily disclosed by entities which aspire to progress to a higher level in their quest to be socially,
environmentally, and ethically responsible.

Principle 1 :
Businesses should conduct and govern themselves with integrity, and in a manner that is
Ethical, Transparent and Accountable.

Essential Indicators

1. Percentage coverage by training and awareness programmes on any of the Principles during the
financial year:

Segment Total number of Topics/principlescovered %age of persons in

training and awareness under the training and its respective category
programmes held impact covered by the awareness
Programmes
Board of Directors This data has not been recorded for FY22. Efforts are underway to record and report this
data from the next financial year.
Key Managerial Personnel
Employees other than BoD
and KMPs
Workers

2. Details of fines/penalties/punishment/award/compounding fees/settlement amount paid in

proceedings (by the entity or by directors/KMPs) with regulators/law enforcement agencies/judicial
institutions, in the financial year, in the following format (Note: the entity shall make disclosures
on the basis of materiality as specified in Regulation 3 - of SEBI (Listing Obligations and Disclosure
Obligations) Regulations, 2015 and as disclosed on the entity’s website):

Monetary
NGRBC Principle Name of the Amount (In INR) Brief of the Case Has an appeal
regulatory/ been preferred?
Enforcement (Yes/No)
agencies/judicial
institutions
Penalty/Fine Nil
Settlement
Compounding fee
Non-Monetary
NGRBC Principle Name of the regulatory/enforcement Brief of the Case Has an appeal
agencies/judicial institutions been preferred?
(Yes/No)
Imprisonment Nil
Punishment

3. Of the instances disclosed in Question 2 above, details of the Appeal/Revision preferred in cases where
monetary or non-monetary action has been appealed.

Case Details Name of the regulatory/enforcement agencies/judicial

institutions
N.A.

4. Does the entity have an anti-corruption or anti-bribery policy? If yes, provide details in brief and if
available, provide a web-link to the policy.
 orporate Governance has been an integral part of the Company’s rich legacy which goes beyond mere legal
C
compliances. The Codes of Conduct for Directors, Independent Directors and Senior Management Personnel, adopted
by the Company, have been hosted on the website of the Company (www.lupin.com). The Company encourages and
promotes a culture of intensive deliberations, transparency and impartiality in its dealings with stakeholders and the
 Corporate Overview Statutory Reports Financial Statements 215

public at large. As a testament of its robust corporate governance practices, the Company enforces Code of Business
Conduct and Ethics (CODE) and empowers employees to report concerns on actual or suspected violations of the
CODE. Employees are at liberty to raise their concerns without any fear of retaliation or retribution and even report
their concerns anonymously. The Company adheres to uncompromising integrity in conduct of business and does
not tolerate corrupt and immoral practices. Company’s operations are guided by strong control systems which are
reviewed by both internal and external auditors at regular intervals.

5. Number of Directors/KMPs/employees/workers against whom disciplinary action was taken by any law
enforcement agency for the charges of bribery/corruption.

FY22 Current Financial Year FY21 Previous Financial Year

Directors 0 0
KMPs 0 0
Employees 0 0
Workers 0 0

6. Details of complaints with regard to conflict of interest:

FY22 Current Financial Year FY21 Previous Financial Year

Number Remarks Number Remarks

Number of complaints received 0 NA 0 NA
in relation to issues of Conflict of
Interest of the Directors
Number of complaints received 0 NA 0 NA
in relation to issues of Conflict of
Interest of the KMPs

7. Provide details of any corrective action taken or underway on issues related to fines/penalties/action
taken by regulators/law enforcement agencies/judicial institutions, on cases of corruption and conflicts
of interest.
Not applicable

Principle 2 :
Businesses should provide goods and services in a manner that is sustainable and safe

Essential Indicators

1. Percentage of R&D and capital expenditure (capex) investments in specific technologies to improve the
environmental and social impacts of product and processes to total R&D and capex investments made
by the entity, respectively.

FY22 Details of improvements in

environmental and social
impacts
R&D Percentage of R&D investments in specific technologies to improve the environmental
and social impacts of product and processes to total R&D will be made available from
FY 2023 -

-
Capex 3.88%
CAPEX initiative Details Investment (INR Mn)

Automation projects – all projects 83.0

which lead to process improvement

Digitization projects – initiatives 46.4

such as Electronic batch records
and Labware LIMS

Environmental projects – installation 137.2

of solar rooftops at various sites,
air and water pollution control
equipment and energy saving
technologies

Note: Percentage of Capex investments in specific technologies to improve the environmental and social impacts of
product and processes to total capex investments has been made available from FY22
216 LUPIN LIMITED Integrated Report 2021-22

2. Does the entity have procedures in place for sustainable sourcing? (Yes/No) b. If yes, what percentage
of inputs were sourced sustainably?
Yes, suppliers are classified into categories — Strategic, Critical, Leverage and Routine — to improve our relationship with
them and minimize the supply risk. We also ensure that periodic evaluations are undertaken for each of the categories:

- Strategic and Critical suppliers are evaluated on a quarterly basis

- Leverage suppliers are evaluated on a half-yearly basis
- Routine suppliers are evaluated on a yearly basis
In FY21, we established a target of implementing a Supplier Code of Conduct (CoC) for all our suppliers and vendors by
2022. This year, we are proud to state that we achieved this by developing our own Third-Party Code of Code which is
applicable to the following stakeholders:
• Supplier
• Vendors
• Distributors
• Wholesalers
• Agents
• Technology Partners
• Contract Manufacturing Organizations (CMO’s)
• Contract Research Organizations (CRO’s)
The CoC covers aspects such as labour rights, anti-bribery and corruption, health and safety, environment, ethics, data
privacy, confidentiality, and information protection.
For more details, please refer to our website: https://www.lupin.com/wp-content/uploads/2022/05/third-party-coc.pdf

3. Describe the processes in place to safely reclaim your products for reusing, recycling, and disposing
at the end of life, for (a) Plastics (including packaging) (b) E-waste (c) Hazardous waste and (d) other
waste

• Post-consumer plastic waste is collected and sent for recycling or co-processing. This is being done through
authorised third parties.
• We disposed our e-wastes as per in country/local regulations.
• Hazardous wastes are being disposed as per the Hazardous Wastes Management Rules.
• The other wastes are disposed as per the local regulatory bodies and the regulations.

4. Whether Extended Producer Responsibility (EPR) is applicable to the entity’s activities (Yes/No). If
yes, whether the waste collection plan is in line with the Extended Producer Responsibility (EPR) plan
submitted to Pollution Control Boards? If not, provide steps taken to address the same.
Yes, as part of our Extended Producer Responsibility obligations around post-consumer plastic waste management, we
are recovering an equivalent quantity of the post-consumer plastic waste generated from our products in India and the
plastic waste is being channelized to create recycled products or being utilised as an alternate energy source. Further, we
have eliminated patient information leaflets from our products by digitising them. In addition to reducing costs, this has
also reduced paper consumption and waste.

5. Of the products and packaging reclaimed at end of life of products, amount (in metric tonnes) reused,
recycled, and safely disposed off:
As part of our Extended Producer Responsibility obligations around post-consumer plastic waste management, we are
recovering an equivalent quantity of the post-consumer plastic waste generated from our products in India and the
plastic waste is being channelized to create recycled products or being utilized as an alternate energy source. Further, we
have eliminated patient information leaflets from our products by digitizing them. In addition to reducing costs, this has
also reduced paper consumption and waste.

6. Reclaimed products and their packaging materials (as percentage of products sold) for each product
category.

Indicate product category Reclaimed products and their packaging materials as

% of total products sold in respective category
Nil Not applicable in any category
 Corporate Overview Statutory Reports Financial Statements 217

Principle 3 :
Businesses should respect and promote the well-being of all employees, including those in their
value chains

Essential Indicators
1. a. Details of measures for the well-being of employees.

Category % of employees covered by

Total Health Accident Maternity Paternity Day Care
(A) insurance insurance benefits Benefits facilities
Number % Number % Number % Number % Number %
(B) (B/A) (C) (C/A) (D) (D/A) (E) (E/A) (F) (F/A)

Permanent employees
Male 17,269 17,155 99.3 17,198 99.5 NA NA 14,191 82.2% - -
Female 1056 994 94.1 991 93.8 1,056 100 NA NA - -
Total 18,325 18,149 - 18,819 - 1,056 - 14,191 - - -
Other than Permanent employees
Male Other than Permanent Employees data has not been recorded in a gender disaggregated manner for
FY22. This will be made available from FY23.
Female
Total 6432

b. Details of measures for the well-being of workers:

Category % of workers covered by

Total Health Accident Maternity Paternity Day Care
(A) insurance insurance benefits Benefits facilities
Number % Number % Number % Number % Number %
(B) (B/A) (C) (C/A) (D) (D/A) (E) (E/A) (F) (F/A)

Permanent workers
Male 1,116 This data 872 78.1 - - 461 83.1 - -
will be made
Female 12 11 91.7 12 100 - - - -
available from
Total 1,128 FY 2023. 883 - 12 - 431 - - -
Other than Permanent workers
Male NA
Female
Total

2. Details of retirement benefits.

Benefits FY22 FY21

No. of No. of workers Deducted and No. of No. of workers Deducted and
employees covered deposited employees covered as deposited
covered as as a % of total with the covered as a a % of total with the
a % of total workers authority % of total workers authority
employees (Y/N/N.A.) employees (Y/N/N.A.)
PF 100 100 Y 100 100 Y
Gratuity 100 100 Y 100 100 Y
ESI 11 39 Y 12 34 Y
Others 4 0 Y 3 0 Y
(Superannuation)
Others (NPS) 3 0 Y 2 0 Y

3. Accessibility of workplaces
Please refer to page number 97 withing the “Diversity and Inclusion” sub section under the “Human Capital Chapter”.
218 LUPIN LIMITED Integrated Report 2021-22

4. Does the entity have an equal opportunity policy as per the Rights of Persons with Disabilities Act,
2016? If so, provide a web-link to the policy.
Please refer to page number 97 withing the “Diversity and Inclusion” subsection under the “Human Capital Chapter”.

5. Return to work and Retention rates of permanent employees and workers that took parental leave.
Permanent employees Permanent workers
Gender Return to work rate Retention rate Return to work rate Retention rate
Male 100% 89% 100% 94%
Female 100% 95% 100% 100%

6. Is there a mechanism available to receive and redress grievances for the following categories of
employees and workers? If yes, give details of the mechanism in brief.
Please refer to page number 104 within the “Grievance Redressal” under the “Influencing Culture” sub-section of the
Human Capital” chapter.

7. Membership of employees and worker in association(s) or Unions recognised by the listed entity:

Category FY22 FY21

Total No. of % Total No. of %
employees/ employees/ (B/A) employees/ employees/ (D/C)
workers in workers in workers in workers in
respective respective respective respective
category (A) category, who category category, who
are part of (C) are part of
association(s) association(s)
or Union (B) or Union
(D)
Total Permanent 0 0 0 0 0 0
Employees
Male 0 0 0 0 0 0
Female 0 0 0 0 0 0
Total Permanent 1,128 772 68.4 1,378 913 66
Workers
Male 1,116 769 68.9 1,366 909 65
Female 12 3 25 12 4 25

8. Details of training given to employees and workers:

Continuous learning and reskilling have always been central to Lupin culture.

Workforce FY22
Total On Health and safety measures On Skill upgradation
(A)
No. % (B/A) No. % (C/A)
(B) (C)
Male
Female Gender disaggregated data on training will be made available from FY 2023.
Total 19,453 Ensuring that our workforce 11,843 60.9%
is effectively trained on
safety issues is crucial
for the success of our
operations, It also aids
in preserving a work
environment that prioritizes
and protects the health and
wellbeing of our workforce.
In line with this, for FY22,
650,698 hours were
imparted on safety training.
Gender-disaggregated
participant training data will
be made available from
FY 2023.
 Corporate Overview Statutory Reports Financial Statements 219

9. Details of performance and career development reviews of employees and worker:

Category FY22 Current Financial Year FY21 Previous Financial Year
Total No. (B) % (B/A) Total No. (D) % (D/C)
(A) (C)
Employees
Male 17,269 17,269 100% Gender disaggregated data has been made
1,056 1,056 available from FY22.
Female 100%
Total 18,325 18,325 100% 100%
Workers
Male NA
Female
Total

10. Health and safety management system:

a. W
 hether an occupational health and safety management system has been implemented by the entity? (Yes/No). If
yes, what is the coverage of such a system?
b. W
 hat are the processes used to identify work-related hazards and assess risks on a routine and non-routine basis by
the entity?
c. W
 hether you have processes for workers to report the work-related hazards and to remove themselves from such
risks.
d. Do the employees/workers of the entity have access to non-occupational medical and healthcare services?
Please refer to page 101 within the “Ensuring Employee Health and Safety” under the “Human Capital” chapter.

11. Details of safety related incidents, in the following format:

Safety Incident/Number Category FY22 FY21
Current Financial Previous Financial
Year Year
Lost Time Injury Frequency Rate (LTIFR) (per one Employees 0.21 0.11
million-person hours worked)
Workers - -
Total recordable work-related injuries Employees 210 258
Workers - -
No. of fatalities Employees Nil Nil
Workers - -
High consequence work-related injury or ill-health Employees 4.37 5.67
(excluding fatalities)
Workers 0 0

12. Describe the measures taken by the entity to ensure a safe and healthy workplace.
Please refer to page 101 within the “Ensuring Employee Health and Safety” under the “Human Capital” chapter.

13. Number of complaints on the following made by employees and workers

FY22 Current Financial Year FY21 Previous Financial Year

Filed during Pending Remarks Filed Pending Remarks
the year resolution at during the resolution at
the end of year the end of
year year
Working Nil
Conditions
Health & Safety

14. Assessments for the year

% of your plants and offices that were assessed

(by entity or statutory authorities or third parties)
Health and safety practices Customer audits & PSCI audits are conducted at majority of sites
Working Conditions Customer audits & PSCI audits are conducted at majority of sites
220 LUPIN LIMITED Integrated Report 2021-22

15. Provide details of any corrective action taken or underway to address safety-related incidents (if any)
and on significant risks/concerns arising from assessments of health & safety practices and working
conditions.
 verall, there was a reduction in the number of accidents and incidents during FY22 as compared to FY21, 21% and
O
10% respectively.

Leadership Indicators

1. Does the entity extend any life insurance or any compensatory package in the event of death of (A)
Employees (Y/N) (B) Workers (Y/N).
Yes, the company extends life insurance or any compensatory package in the event of death for it workforce.

Principle 4 :
Businesses should respect the interests of and be responsive to all its stakeholders

Essential Indicators

1. Describe the processes for identifying key stakeholder groups of the entity.
Any individual or group of individuals or institution that adds value to the business chain of the Company is identified as
a core stakeholder. This inter alia includes employees, shareholders and investors, suppliers, customers, channel partners
and key partners, regulators, lenders, research analysts, communities, and non-governmental organisations, amongst
others. We are privileged to share a strong relationship with our stakeholders based on our deep understanding of their
expectations and our commitment to fulfil them
2. List stakeholder groups identified as key for your entity and the frequency of engagement with each
stakeholder group.

Key Stakeholders Whether identified Channels of communication Frequency of Purpose and scope of
as Vulnerable & (Email, SMS, Newspaper, engagement engagement including
Marginalised Group Pamphlets, Advertisement, (Annually/ key topics and
(Yes/No) Community Meetings, Half yearly/ concerns raised during
Notice Board, Website), Quarterly/ such engagement
Others others – please
specify)

Employees No Direct & other Continuous Learning opportunities,

communication mechanisms building a safety
including mailers, Intranet, culture, and inculcating
employee committees, safe work practices
engagement initiatives, among employees, and
newsletters improving diversity and
inclusion.
Shareholders/ No Press Releases, Social Frequent and Educating them about
Investors Media, Website, Analyst need based Lupin’s business
meets, Analyst briefings, strategy for the long-
quarterly results, Annual term, to stay abreast
General Meetings, Integrated of developments in the
Report, Financial Reports, Corporation and its
email advisories, Intimation subsidiary companies
to stock exchanges, and understanding their
annual/ quarterly financials, expectations
and investor meetings/
conferences
Customers Yes, if they qualify Customer meets, mailers, Frequent and For stronger customer
based on specified news bulletins, brochures, need based relationships. To enhance
criteria such as social media, website business. Stay in touch
income, etc. with them to understand
the industry and business
challenges and address
any issues that the
customers may have

Channel Partners, No Partner meets and events, Frequent and Stroger partnerships,
franchises, and key mailers, news bulletins, need based helps to increase reach
partners brochures, social media, and enhance business,
website ethical business, and fair
business practices and
governance
 Corporate Overview Statutory Reports Financial Statements 221

Key Stakeholders Whether identified Channels of communication Frequency of Purpose and scope of
as Vulnerable & (Email, SMS, Newspaper, engagement engagement including
Marginalised Group Pamphlets, Advertisement, (Annually/ key topics and
(Yes/No) Community Meetings, Half yearly/ concerns raised during
Notice Board, Website), Quarterly/ such engagement
Others others – please
specify)
Regulators No Working committee Need based For good governance
meetings, email, one-on- and compliance.
one meetings, conceals, Discussions with regards
conferences, seminars, and to various regulations
forums and amendments,
inspections, and
approvals.
Research Analysts No Website, social media, Frequent and Keep abreast of
Email, one-on-one meetings, need based developments of the
conceals, videoconference, Corporation and its
and forums subsidiaries

Communities and Yes Site visits, meetings, press Frequent and Understand areas
NGOs releases, project meetings, need based of sustainable
consultative sessions, development, manage
social media, participation Lupin’s brand and
in events, case studies, reputation, work
brochures, and emails in partnership to
develop solutions to
challenging areas,
improve livelihood,
access to healthcare
and education. Support
socially high impact
projects

Leadership Indicators

1. P
 rovide the processes for consultation between stakeholders and the Board on economic, environmental, and social
topics or if consultation is delegated, how is feedback from such consultations provided to the Board.
Consultation with stakeholders on E, S and G topics are delegated to the departments within the Company who are
also responsible for engaging with stakeholders continually. The Company has always maintained that a constant and
proactive engagement with our key stakeholders enables Lupin to better communicate its strategies and performance.
A continuous engagement helps align expectations, thereby enabling Lupin to better serve its stakeholders. Material
topics were shortlisted and prioritized based on their impact on our stakeholders and our business. The monthly ESG core
committee meetings provide us an opportunity to share feedback on these consultations.

2. Whether stakeholder consultation is used to support the identification and management of environmental, and
social topics (Yes/No). If so, provide details of instances as to how the inputs received from stakeholders on these
topics were incorporated into policies and activities of the entity.
We have framed our ESG agenda on material topics from stakeholder consultations. Material topics were shortlisted and
prioritized based on their impact on our stakeholders and our business. Our ESG priorities are determined through data-
driven and consultative exercise.

3. P
 rovide details of instances of engagement with, and actions taken to, address the concerns of vulnerable/
marginalised stakeholder groups.
Lupin Human Welfare and Research Foundation (LHWRF) was set up with the mission to provide an alternative model
of rural development which is sustainable, replicable, and ever evolving, essentially empowering underprivileged and
marginalised sections of society and providing basic infrastructure and balanced ecological base to the villages. The
foundation engages with the community in a variety of areas that serve the vulnerable/marginalised stakeholder groups.
Read about our foundation on https://www.lupinfoundation.in/
222 LUPIN LIMITED Integrated Report 2021-22

Principle 5 :
Businesses should respect and promote human rights

Essential Indicators
1. E
 mployees and workers who have been provided training on human rights issues and policy(is) of the entity, in the
following format:
This data is not being reported for FY22.
2. Details of minimum wages paid to employees and workers, in the following format

Category Permanent Employees Permanent Workers

Male Female Male Female
Getting wage equal to minimum wage 35 2 0 0
Getting wage more than minimum wage 17,234 1,054 1,116 12

3. Details of remuneration/salary/wages, in the following format:

Category Male Female

Number Median Number Median
remuneration/ remuneration/
salary/wages salary/wages
(INR Mn) (INR Mn)
Executive Directors 2 75.79 1 144.92
Board of Directors (Non-Executive and Non-Independent) 1 40.30 1 6.70
Board of Directors (Non-Executive and Independent) 3 7.83 2 8.01
Key Managerial Personnel (Company Secretary) 1 9.13 - -
Employees other than BoD and KMP 17,262 0.50 1,052 0.52
Workers 1,116 0.44 12 0.57

4. D
 o you have a focal point (Individual/Committee) responsible for addressing human rights impacts or issues caused
or contributed to by the business? (Yes/No)
Please refer to page number 105 within the “Global HR Policies” subsection of the “Human Capital” Chapter.
5. Describe the internal mechanisms in place to redress grievances related to human rights issues.
Please refer to page number 105 within the “Global HR Policies” subsection of the “Human Capital” Chapter.
6. Number of Complaints on the following made by employees and workers:

FY22 Current Financial Year

Filed during Pending resolution at the Remarks
the year end of year
Sexual Harassment 0 0 NA
Discrimination at workplace 2 0 NA
Child Labour 0 0 NA
Forced Labour/Involuntary Labour 0 0 NA
Wages 0 0 NA
Other human rights related issues 0 0 NA

Note: This data has been made available from FY22

7. Mechanisms to prevent adverse consequences to the complainant in discrimination and harassment cases.
Please refer to page number 104 within the “Inculcating a Culture of Talent Engagement” under the “Human Capital”
chapter.
8. Do human rights requirements form part of your business agreements and contracts? (Yes/No)
Yes.
9. Assessments of the year
Lupin internally monitors compliance for all relevant laws and policies pertaining to these Human Right issues. There have
been no observations by local statutory/third parties in India in FY22.
10. Provide details of any corrective actions taken or underway to address significant risks/concerns arising from the
assessments at Question 9 above.
Not Applicable
 Corporate Overview Statutory Reports Financial Statements 223

Principle 6 :
Businesses should respect and make efforts to protect and restore the environment

Essential Indicators

1. Details of total energy consumption (in Joules or multiples) and energy intensity, in the
following format:
Parameter FY 2021-22 FY 2020-21
(Current Financial Year) (Previous Financial Year)
Total electricity consumption (A) 1,289,682 GJ 1,343,827 GJ
Total fuel Diesel 64,173 GJ 65,349 GJ
consumption (B)
Furnace Oil 408,105 GJ 669,918 GJ
Natural Gas 372,486 GJ 233,878 GJ
Low Sulphur Heavy 23,296 GJ -
Stock (LSHS) fuel
Energy consumption through Solar Captive generation 5,713 GJ 5,688 GJ
other sources (C)
Steam generated from 110,538 GJ 105,175 GJ
agro-waste
Coal based steam 710,657 GJ 975,105 GJ
purchase
Wind – grid 46,874 GJ 37,228 GJ
Agro-waste based steam 91,694 GJ 227,605 GJ
purchase
Total energy consumption (A+B+C) 3,123,218 GJ 3,663,773 GJ
Energy intensity per million rupees of turnover 26.53 33.61
(Total energy consumption/turnover in million rupees)

Note: Indicate if any independent assessment/evaluation/assurance has been carried out by an external agency?
(Y/N) If yes, name of the external agency.
No
2. Does the entity have any sites/facilities identified as designated consumers (DCs) under the Performance, Achieve
and Trade (PAT) Scheme of the Government of India? (Y/N) If yes, disclose whether targets set under the PAT
scheme have been achieved. In case targets have not been achieved, provide the remedial action taken, if any.
Not applicable

3. Provide details of the following disclosures related to water, in the following format:

Parameter FY 2021-22 FY 2020-21

(Current Financial Year) (Previous Financial Year)
(i) Surface water 130,614 KL 120,077 KL
(ii) Groundwater 173,300 KL 201,708 KL
(iii) Third party water (Municipal water supplies, etc.) 1,357,253 KL 1,492,112 KL
Total volume of water withdrawal (in kilolitres) 1,661,168 KL 1,813,897 KL
(i + ii + iii)
Total volume of water consumption (in kilolitres) 2,369,480 KL 2,559,253 KL

Water intensity per rupee of turnover 20.13 KL/INR Mn turnover

(Water consumed/turnover)

Note: Indicate if any independent assessment/evaluation/assurance has been carried out by an external agency?
(Y/N) If yes, name of the external agency.
No

4. Has the entity implemented a mechanism for Zero Liquid Discharge? If yes, provide details of its coverage
and implementation.
Lupin has achieved Zero Liquid Discharge status in almost 50% of Indian manufacturing sites in accordance with the
standards prescribed by regulatory authorities.
224 LUPIN LIMITED Integrated Report 2021-22

5. Please provide details of air emissions (other than GHG emissions) by the entity, in the following format:
We are currently not tracking this information at a Group level. We will make this data available from FY 2023.
Note: Indicate if any independent assessment/evaluation/assurance has been carried out by an external agency? (Y/N) If
yes, name of the external agency.
N/A
6. Provide details of greenhouse gas emissions (Scope 1 and Scope 2 emissions) & its intensity, in the following format:
Parameter Unit FY 2021-22 FY 2020-21
(Current Financial Year) (Previous Financial Year)
Total Scope 1 emissions (includes emissions Metric tonnes of CO2 85,845 100,525
from energy consumption, fugitive emissions equivalent
and emissions from owned vehicles)
Total Scope 2 emissions Metric tonnes of CO2 equivalent 359,447 387,151
Total Scope 1 and Scope 2 emissions per tonnes of CO2 equivalent/ 3.78 4.47
rupee of turnover Million INR
Note: Indicate if any independent assessment/evaluation/assurance has been carried out by an external agency?
(Y/N) If yes, name of the external agency.
No
7. Does the entity have any project related to reducing Green House Gas emission? If Yes, then provide details: -
Our GHG emission reduction initiatives have been enlisted in the manufacturing capital and natural capital section of the
Integrated Report. We have also adopted an ambitious target to reduce our Scope 1 and Scope 2 GHG emissions by 15%
by 2030. Our GHG emission reductions include:

 Transition to natural gas in Tarapur and Pithampur, which is less emission intensive than furnace oil.
  he contribution of renewable power at our Ankleshwar and Dabhasa site in FY22 has increased by 5.30 MW by
T
switching to a hybrid renewable power model comprising wind and solar.
  he procurement of renewable electricity is critical for us to reduce our dependence on the grid electricity generated
T
from fossil fuels. We are exploring ways to increase the procurement of renewable energy from the grid.
  e also replaced old conventional luminaries by energy-efficient LED lights. A total of 4,404 lights were
W
replaced at Mandideep, Ankleshwar, Vizag and Dabhasa.
  e have replaced AC motors with DC electronically commuted motors in AHU’s, which has resulted in energy
W
efficiency and power cost savings
Our commitment to climate stewardship also contributes to product innovation in the development phase. Lupin Healthcare
UK’s product, Luforbec has recently achieved Carbon neutrality certification. Lupin Healthcare offsets the total emissions
from the production, use and disposal of the inhaler, thus achieving carbon neutrality. This is expected to significantly
augment the NHS’ green agenda to achieve net zero emissions.
8. Provide details related to waste management by the entity, in the following format:
For each category of waste generated, total waste disposed by nature of disposal metho (in metric tonnes)

FY 2021-22 FY 2020-21
Category of waste
Hazardous waste (MT) Hazardous waste (MT)
(i) Pre-processing/co-processing to cement kilns/incineration 6,954 8,653
(ii) Landfilling 12,940 17,397
(iii) Other disposal operations - sent for co-processing to 3,099 4,917
cement kilns
(iv) Recycling/Recovery/Utilisation 14,229 14,862
Total (i + ii + iv) 34,123 40,912

Category of waste FY 2021-22 FY 2020-21

Non-hazardous waste (MT) Non-hazardous waste (MT)
(i) Canteen waste and Mycelia waste sent for recycling – 5,844 3,515
feed for piggeries/composting
(ii) Agro-waste boiler ash sent for brick manufacturing, soil 1,500 1,946
enrichment and landfilling
Total 7,344 5,461

Note: Indicate if any independent assessment/evaluation/assurance has been carried out by an external agency? (Y/N) If
yes, name of the external agency.
No
 Corporate Overview Statutory Reports Financial Statements 225

9. B
 riefly describe the waste management practices adopted in your establishments. Describe the strategy adopted by
your company to reduce usage of hazardous and toxic chemicals in your products and processes and the practices
adopted to manage such wastes.

Lupin strives to embed principles of circularity and waste recycling to reduce waste disposal to landfills or incineration.
The incinerable hazardous waste generated at the site is sent for co-processing/ pre-processing in cement plants instead
of incineration.
Spent solvents generated in the API manufacturing processes are either recovered and reused in-situ or sent to the
authorized recyclers or registered disposal facilities. Further as a part of our resource conservation initiatives the spent
calcium sulphate is sent to the cement plants for utilizing this as alternate fuel and raw material in their operations.
Non-hazardous waste from our operations, such as canteen wastes, and mycelia wastes are either sent to piggeries or
composted to convert it into usable organic fertilizer. The agro-waste boiler ash was sent for brick manufacturing, soil
enrichment and landfilling.
We are committed to minimizing waste by:
 Encouraging non-hazardous and less toxic materials during the inventory/purchase process
 Sourcing equipment that produces zero waste or minimal hazardous waste
 Using longer life chemical products
 Training employees on safe handling, labelling and storage of hazardous products
All of our waste management practices have been detailed in the Natural Capital section of the Integrated Report

10. If the entity has operations/offices in/around ecologically sensitive areas (such as national parks, wildlife
sanctuaries, biosphere reserves, wetlands, biodiversity hotspots, forests, coastal regulation zones etc.) where
environmental approvals/clearances are required, please specify details in the following format:

S. Location of operations/ Type of operations Whether the conditions of environmental approval/

No. offices clearance are being complied with? (Y/N) If no, the
reasons thereof and corrective action taken, if any.
1 Not Applicable

11. Details of environmental impact assessments of projects undertaken by the entity based on applicable laws, in the
current financial year:

Name and brief EIA Notification Date Whether conducted by independent Results communicated in public
details of project No. external agency (Yes/No) domain (Yes/No)
Not Applicable

12. I s the entity compliant with the applicable environmental law/ regulations/ guidelines in India; such as the Water
(Prevention and Control of Pollution) Act, Air (Prevention and Control of Pollution) Act, Environment protection
act and rules thereunder (Y/N).
Yes

Leadership Indicators

1. P
 rovide break-up of the total energy consumed (in Joules or multiples) from renewable and non-renewable sources,
in the following format:

Parameter FY 2021-22 FY 2020-21

(Current Financial Year) (Previous Financial Year)
From renewable sources
Total electricity consumption (A) Solar – captive generation 5,713 GJ 5,688 GJ
Wind – grid 46,874 GJ 37,228 GJ

Total fuel consumption (B) - -

Energy consumption through other Steam generated from agro-waste 110,538 GJ 105,175 GJ
sources (C) Agro-waste based steam purchase 91,694 GJ 227,605 GJ

Total energy consumed from renewable sources (A+B+C) 254,819 GJ 375,696 GJ

226 LUPIN LIMITED Integrated Report 2021-22

From non-renewable sources FY 2021-22 FY 2020-21

(Current Financial Year) (Previous Financial Year)
Total electricity consumption (D) 1,289,682 GJ 1,343,827 GJ

Total fuel consumption (E) Diesel 64,173 GJ 65,349 GJ

Furnace Oil 408,105 GJ 669,918 GJ
Natural Gas 372,486 GJ 233,878 GJ
Low Sulphur Heavy Stock 23,296 GJ -
(LSHS) fuel
Energy consumption through other Coal based steam purchase 710,657 GJ 975,105 GJ
sources (F)
Total energy consumed from non-renewable sources (D+E+F) 2,868,398 GJ 3,288,076 GJ

Note: Indicate if any independent assessment/evaluation/assurance has been carried out by an external agency? (Y/N) If
yes, name of the external agency.
No
3. Water withdrawal, consumption and discharge in areas of water stress (in kilolitres):
Five of companies operating locations – Indore, Nagpur, Jammu, Aurangabad and Ankleshwar - are in regions of
Extremely High-Water Risk by WRI Aqueduct water risk atlas tool. Company’s strategy for ensuring business continuity
and water risk mitigation includes technical interventions such as the installation of water recycling plants, reusing AHU
condensate and rainwater, water efficiency mechanisms, and raising awareness about water conservation among their
stakeholders.
5. W
 ith respect to the ecologically sensitive areas reported at Question 10 of Essential Indicators above, provide
details of significant direct & indirect impact of the entity on biodiversity in such areas along-with prevention and
remediation activities.
Not applicable
6. I f the entity has undertaken any specific initiatives or used innovative technology or solutions to improve resource
efficiency, or reduce impact due to emissions/effluent discharge/waste generated, please provide details of the
same as well as outcome of such initiatives, as per the following format:
The details have been provided in manufacturing capital chapter and natural capital chapter.
8. D
 isclose any significant adverse impact to the environment, arising from the value chain of the entity. What
mitigation or adaptation measures have been taken by the entity in this regard.
None
9. Percentage of value chain partners (by value of business done with such partners) that were assessed for
environmental impacts.
None
Principle 7 :
Businesses, when engaging in influencing public and regulatory policy, should do so in a
manner that is responsible and transparent

Essential Indicators

1. a. Number of affiliations with trade and industry chambers/associations: 12

b. List the top 10 trade and industry chambers/associations (determined based on the total members of such a
body) the entity is a member of/affiliated to.

S. No. Name of the trade and industry chambers/ Reach of trade and industry chambers/ associations
associations (State/National)
1 Federation of Indian Chambers of Commerce and National
Industry (FICCI)
2 Confederation of Indian Industry (CII) National
3 Associated Chambers of Commerce and Industry of National
India (ASSOCHAM)
4 Indian Drug Manufacturers Association (IDMA) National
5 Foundation of Pharma Entrepreneurs (FOPE) National

2. P
 rovide details of corrective action taken or underway on any issues related to anti competitive conduct by the
entity, based on adverse orders from regulatory authorities.
Not applicable
 Corporate Overview Statutory Reports Financial Statements 227

Principle 8 :
Businesses should promote inclusive growth and equitable development

Essential Indicators

1. D
 etails of Social Impact Assessments (SIA) of projects undertaken by the entity based on applicable laws, in the
current financial year.

Name and brief SIA Date of Whether Results Relevant Web

details of project Notification notification conducted by communicated link
No. independent in public domain
external (Yes/No)
agency (Yes/No)

Not applicable

2 Provide information on project(s) for which ongoing Rehabilitation and Resettlement (R&R) is being undertaken by
your entity, in the following format:

S. No. Name of Project State District No. of Project Affected % of PAFs covered Amounts paid to
for which R&R is Families (PAFs) by R&R PAFs in the FY
ongoing (In INR)

Not applicable

3. D
 escribe the mechanisms to receive and redress grievances of the community.
The communities we work with are treated as equal partners in development and are engaged in the implementation of
the projects from the very beginning. The work is monitored by the community and upon its completion, the Panchayat
takes responsibility for the same. To redress grievances that may arise, we have developed rules and procedures at village
institution levels for timely resolutions.

4. Percentage of input material (inputs to total inputs by value) sourced from suppliers:

FY22 Current Financial Year FY21 Previous Financial Year

Directly sourced from MSMEs/small producers 2,664 3,136

Sourced directly from within the district and Not available

neighboring districts

Leadership Indicators

1. P
 rovide details of actions taken to mitigate any negative social impacts identified in the Social Impact Assessments
(Reference: Question 1 of Essential Indicators above):
None

2. P
 rovide the following information on CSR projects undertaken by your entity in designated aspirational districts as
identified by government bodies:

S. State Aspirational District Amount spent

No. (In INR lakhs)
1 Assam Amoni - TDF Amoni - The Tribal Development Fund WADI project 438.53
started at Amoni on 30th March 2016. It is 7 years project funded by
NABARD and involve orchrd development and livelihood support
through vegetable cultivation. The project supports 500 farmer
families and 50 landless families.

2 Maharashtra Padalpur - TDF Padalpur - The Tribal Development Fund WADI 447.27
project started at Padalpur on 30th March 2016 too like Amoni. It is
also 7 years project funded by NABARD and have same number of
families covered.

3 Maharashtra Akkalkuwa - TDF Akkalkuwa - This is recently started Tribal 415.54

Development Fund WADI project that covers 600 families
228 LUPIN LIMITED Integrated Report 2021-22

S. State Aspirational District Amount spent

No. (In INR lakhs)

4 Maharashtra IWMS Moramba - This Integrated water Management System 40.42

Project is supported by NABARD The Project covers 5 villages
(Moramba, Mahukhadi, Kakdiamba,Khadkuna,Umarkuwa) of
Akkalkuwa block. The project treats about 100 acres of land in each
of the five villages, thus covering total 500 Acres area. Currently,
Capacity Building Phase (CBP) of the project has began. Key
project components are : 1. Soil and water conversion (2) Crop
and land development (3) Capacity building and demonstration.
The project has NRM focus and the total spent includes beneficiary
contribution and share from LHWRF
5 Maharashtra IWMS Khadkuna 40.73

6 Maharashtra IWMS Mahukhadi 41.59

7 Maharashtra IWMS Kakdiamba 40.54

8 Maharashtra CCA Shendhavan - This Climate Change Adaptation project funded 59.54
by NABARD has components of Soil and water conservation, soil
health for productivity enhancement, Sustainable NRM, CCA farming
practices & nutritional security. It aims to build the adaptive capacity
of farmers through livelihood development. The project also includes
provision of weather and crop based agricultural advisories to
farmers to cope with climate change

9 Maharashtra Nandurbar - FPO Astamba - Agricultural inputs for farmers through bulk 11.44
purchasing and marketing of agricultural produce are the focus of the FPOs
10 Maharashtra Nandurbar - FPO Akkarani 11.13
11 Maharashtra Nandurbar - FPO Ranikajal 11.13

12 Maharashtra Nandurbar Skill Development Training Programs for Livelihood 44.46

Promotion of Tribal Youths & Women —Lupin Human Welfare and
Research Foundation (LHWRF)(NABSKILL Programme) The project
duration is of two years.

13 Maharashtra Nandurbar E-shakti - CBO/ NGO Capacity Building through 25

digitalisation of SHG accounts.

14 Maharashtra ACCF-This project funded by Atlas Copco entails livelihood 411

development of tribal families through the Group Well Irrigation
system in Nandurbar district of Maharashtra at Akkalkuwa Block

15 Maharashtra BRLF-This Integrated water Management System Project is supported 55.63

by NABARD The Project covers 5 villages (Moramba, Mahukhadi,
Kakdiamba,Khadkuna,Umarkuwa) of Akkalkuwa block. The project
treats about 100 acres of land in each of the five villages, thus covering
total 500 Acres area.

16 Maharashtra Better Cotton Initiative- The Better Cotton Initiative (BCI) aims to make 800
global cotton production better for the people who produce it, better
for the environment it grows in and better for the sector’s future, by
developing Better Cotton as a sustainable mainstream commodity. It
involves training and capacity building of farmers for sustainable cotton
production by promotion of best package of practices on integrated
pest management, integrated nutrient management, and selection of
variety by conducting training, exposure of farmers and demonstrations
at village level. Lupin Human Welfare and Research Foundation (LHWRF)
is implementing this BCI project with small landholder cotton growers in
Dhule and Nandurbar districts since 2017-18.
 Corporate Overview Statutory Reports Financial Statements 229

S. State Aspirational District Amount spent

No. (In INR lakhs)

17 Rajasthan Dholpur - Health and Nutrition Program 27.50

18 Rajasthan Dholpur - Agriculture/Animal Husbandry & WRD 36.60

19 Rajasthan Dholpur - Infrastructure Development 48

20 Rajasthan Dholpur - Livelihood support 1.98

21 Rajasthan Dholpur - Skill Development and Financial Inclusion 15

22 Madhya Pradesh Vidisha - Health & Nutrition 53.48

23 Madhya Pradesh Vidisha - Education 11.14
24 Madhya Pradesh Vidisha - Agriculture and water resources 145.19
25 Madhya Pradesh Vidisha - Skill Development 65.80
26 Madhya Pradesh Vidisha - Financial inclusion 8.30
27 Madhya Pradesh Vidisha - Basic infrastructure 5.28

6. Details of beneficiaries of CSR Projects:

Details of the number of beneficiaries of CSR projects has been provided in the Social & Relationship capital section of the IR.

Principle 9 :
Businesses should engage with and provide value to their consumers in a responsible manner

Essential Indicators

1. D
 escribe the mechanisms in place to receive and respond to consumer complaints and feedback.
To address customer grievances, we have instituted robust mechanisms and processess. Our Pharmacovigilance function
is the nodal agency to monitor the quality and safety of our products. We also have our dedicated team to track and
address customer grievances and complaints.

2. Turnover of products and/services as a percentage of turnover from all products/service that carry information about:
Lupin’s products are Pharmaceutical medicines and drugs, therefore all our products contain information such as
guidance on Storage Conditions, handling, dosage, expiry, etc. Some of the products also contain information on lifestyle
management and a WhatsApp Number/QR code for the benefit of patients to get their queries answered in various
languages for different therapies. Some of our packaging material is manufactured out of recycled papers to reduce
impact on the environment.
3. Number of consumer complaints in respect of the following:

FY22 Remarks FY21 Remarks

(Current Financial Year) (Previous Financial Year)
Received Pending Received Pending
during the resolution at during the year resolution at end
year end of year of year
Data privacy Nil Nil

Advertising Nil OTC: ASCI OTC: Resolved OTC: Provided

queried on successfully robust 3rd party
data source data source
of Lupizyme and allowed a
claim in its TV stronger claim
advertisement.
230 LUPIN LIMITED Integrated Report 2021-22

FY22 Remarks FY21 Remarks

(Current Financial Year) (Previous Financial Year)
Received Pending Received Pending
during the resolution at during the year resolution at end
year end of year of year

Cyber- Nil Nil

security7

Delivery of Nil Nil

essential
services

Restrictive Nil Nil

Trade
Practices

Unfair Trade Nil Nil

Practices

Other - Drug 30,000 All Adverse drug 19,500 All Adverse drug
Safety reports with reports with
Lupin products Lupin products
received at DSRM received at DSRM
are appropriately are appropriately
handled, i.e., handled, i.e., reports
the reports are are processed in
processed in the the global company
global company safety database,
safety database, thoroughly
thoroughly reviewed, medically
reviewed, assessed, and
medically submitted to
assessed, and global regulatory
submitted to authorities
global regulatory (wherever
authorities applicable)
(wherever
applicable)

4. Details of instances of product recalls on account of safety issues:

Number Reasons for recall

Voluntary recalls 12 The products were recalled to ensure our alignment to the
highest standards of quality.
Forced recalls Nil Nil

5. Does the entity have a framework/policy on cyber security and risks related to data privacy? (Yes/No) If available,
provide a web-link of the policy.
Yes. Company has defined and implemented a global Privacy Policy that is applicable to all its legal entities and
businesses. This can be accessed on our website: https://www.lupin.com/privacy-policy/
 Corporate Overview Statutory Reports Financial Statements 231

6. P
 rovide details of any corrective actions taken or underway on issues relating to advertising, and delivery of
essential services; cyber security and data privacy of customers; re-occurrence of instances of product recalls;
penalty/action taken by regulatory authorities on safety of products/services.
The details are provided across our IR sections on the relevant topics.

Leadership Indicators

1. C
 hannels/platforms where information on products and services of the entity can be accessed (provide web link,
if available)8.
https://www.lupin.com/our-products/product-finder/
Lupin has a website which provide all necessary information on the company. For further information visit the link,
https://www.lupin.com/about-us
2. Steps taken to inform and educate consumers about safe and responsible usage of products and/or services8.
https://www.lupin.com/our-products/over-the-counter-otc/
3. Mechanisms in place to inform consumers of any risk of disruption/discontinuation of essential services8.
We inform regulatory authorities before discontinuation of any drugs falling into National List of Essential Medicines.
If regulatory authorities ask us to continue any such medicine, we continue to manufacture until we get permission to
discontinue.
4. Does the entity display product information on the product over and above what is mandated as per local laws?
(Yes/No/Not Applicable) If yes, provide details in brief. Did your entity carry out any survey with regard to
consumer satisfaction relating to the major products/services of the entity, significant locations of operation of the
entity or the entity as a whole? (Yes/No)8
Not applicable, we publish all information required under law on the product.
6. Provide the following information relating to data breaches9:
a. Number of instances of data breaches along-with impact - Zero
b. Percentage of data breaches involving personally identifiable information of customers - Not applicable

For and on behalf of the Board of Directors

Nilesh D. Gupta
Managing Director
(DIN: 01734642)
Mumbai, May 18, 2022